Standard BioTools Inc.

US$0.64As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LABHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (17.97%)
Div yield —
ROE (7.79%)
Medical Devices
Beta (5Y) 1.51
PE TTM 1.861
TSR TTM (47.00%)
Mkt cap US$249.7M
ROIC (5.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.783
23.03%
54.03%
Hold 5|8|4|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
29.77%
18.54%
14.13%
12.43%
Revenue$M
27.66
28.36
27.64
28.15
3.35%
0.41%
(1.69%)
2.01%
Peers (US$249.7M)
Cap (US$)
PE
274.2M
31.10x
262.1M
—
244.0M
139.2x
Capital
TTM
5Y
10Y
Leveragex
0.103
(2.245)
(2.293)
EBIT/Intx
0.812
1.985
1.989
Own earn%
(85.79)
8.50
0.27
Sh yield%
26.60
17.81
18.10
Owners
Insiders/Inst%
2.95
64.75
Short interest%
0.75
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
17–26
$1 testx
—
Incr. ROIC%
0